Mathieu Chevalier

Assistant Professor

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Mathieu Chevalier is an Assistant Professor at INSERM U976, Institut de Recherche Saint-Louis, Université de Paris, France. His research focuses on immunology, specifically in the context of transplant biology and cancer. Recent articles highlight his work on the control of viral infections post-kidney transplantation, the immune responses in stem cell transplantation, and the role of specific T-cell populations in cancer therapy.

Articles (11)

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (10)

Aurélien Corneau

Sorbonne Université Campus Pierre et Marie Curie

FRANCE

View details

Markus Maeurer

University of Mainz

GERMANY

View details

David Michonneau

Professor

Assistance Publique - Hôpitaux de Paris

FRANCE

View details

laurence ZITVOGEL

Université Paris-Saclay

FRANCE

View details

Nicolas VALLET

Assistant Professor

Université de Tours Faculté de Médecine

FRANCE

View details

Sylvain Nguyen

University of Oxford

UNITED KINGDOM

View details

David Gfeller

University of Lausanne

SWITZERLAND

View details

Safae TERRISSE

INSERM

FRANCE

View details

Sophie Caillat-Zucman

Professeur

Université Paris Diderot

FRANCE

View details

Beat Roth

Lausanne University Hospital

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mathieu Chevalier

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Donor HLA-DQ genetic and functional divergence impact the control of BK polyoma virus infection after kidney transplantation

Deciphering bone marrow engraftment after allogeneic stem cell transplantation in humans using single cell analyses

Human MAIT cells inhibit alloreactive T-cell responses and protect from acute graft-versus-host disease

Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse

The polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in cancer patients and healthy individuals.

Real-world characteristics of T-cell apheresis and clinical response to tisagenlecleucel in B-cell lymphoma

Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments

Siglec-7 May Limit Natural Killer Cell-mediated Antitumor responses in Bladder Cancer Patients.

Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapy.

Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients.

Association of Plasma Soluble Vascular Cell Adhesion Molecule-1 and sCD14 With Mortality in HIV-1-Infected West African Adults With High CD4 Counts.

Collaborators (10)

Aurélien Corneau

Markus Maeurer

David Michonneau

laurence ZITVOGEL

Nicolas VALLET

Sylvain Nguyen

David Gfeller

Safae TERRISSE

Sophie Caillat-Zucman

Beat Roth

Make your next move.